Literature DB >> 25378050

Change in storage symptoms following laser prostatectomy: comparison between photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP).

Min Chul Cho1, Seung Beom Ha, Seung-June Oh, Soo Woong Kim, Jae-Seung Paick.   

Abstract

PURPOSE: To compare serial changes of postoperative storage symptoms between PVP and HoLEP, and to identify the predictors influencing postoperative improvement of storage symptoms.
METHODS: A total of 486 men (PVP group: 213 cases; HoLEP group: 273 cases), in whom 12-month follow-up data were available, were included in this retrospective study. Surgical outcomes were evaluated at 1-, 3-, 6-, and 12 months postoperatively using the IPSS, uroflowmetry with post-void residual urine volume (PVR) and serum PSA levels. Improvement of storage symptoms was defined as a reduction by ≥50 % of the subtotal storage symptom score postoperatively compared to baseline.
RESULTS: In both PVP and HoLEP groups, total IPSS, quality-of-life index, frequency score, nocturia score, maximum flow rate and PVR were significantly decreased compared to baseline starting from 1 month after surgery. Whereas urgency score was numerically increased compared to baseline at 1 month after PVP, it was reduced compared to baseline at 1 month after HoLEP. While the subtotal storage symptom score was significantly decreased compared to baseline starting from 3 months after PVP, it was significantly reduced starting from 1 month after HoLEP. On logistic regression analysis, a higher baseline subtotal storage symptom score was the only independent predictor of improvement in storage symptoms after PVP or HoLEP.
CONCLUSIONS: Our data suggest that improvement in storage symptoms after HoLEP begins earlier than that after PVP. Also, this study indicates that patients with more severe baseline storage symptoms have a higher likelihood of improvement after PVP or HoLEP compared to those with less severe symptoms.

Entities:  

Mesh:

Year:  2014        PMID: 25378050     DOI: 10.1007/s00345-014-1424-0

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  19 in total

1.  Impact of LUTS using bother index in DAN-PSS-1 questionnaire.

Authors:  Jukka T Häkkinen; Matti Hakama; Heini Huhtala; Rahman Shiri; Anssi Auvinen; Teuvo L J Tammela; Juha Koskimäki
Journal:  Eur Urol       Date:  2006-06-23       Impact factor: 20.096

2.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

3.  Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate.

Authors:  Min Chul Cho; Ji Hyun Park; Min Su Jeong; Jun-Seok Yi; Ja Hyeon Ku; Seung-June Oh; Soo Woong Kim; Jae-Seung Paick
Journal:  Neurourol Urodyn       Date:  2011-04-28       Impact factor: 2.696

Review 4.  Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.

Authors:  Sascha A Ahyai; Peter Gilling; Steven A Kaplan; Rainer M Kuntz; Stephan Madersbacher; Francesco Montorsi; Mark J Speakman; Christian G Stief
Journal:  Eur Urol       Date:  2010-06-11       Impact factor: 20.096

5.  Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate.

Authors:  Thomas Hermanns; Tullio Sulser; Markus Fatzer; Martin K Baumgartner; Julien M Rey; Markus W Sigrist; Hans-Helge Seifert
Journal:  Eur Urol       Date:  2008-03-27       Impact factor: 20.096

6.  Assessing symptom improvement after elective prostatectomy for benign prostatic hypertrophy.

Authors:  A B Flood; N A Black; K McPherson; J Smith; G Williams
Journal:  Arch Intern Med       Date:  1992-07

7.  Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.

Authors:  Narihito Seki; Kohei Yuki; Mineo Takei; Akito Yamaguchi; Seiji Naito
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

Review 8.  A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate.

Authors:  Richard Naspro; Alexander Bachmann; Peter Gilling; Rainer Kuntz; Stephan Madersbacher; Francesco Montorsi; Oliver Reich; Christian Stief; Ivano Vavassori
Journal:  Eur Urol       Date:  2009-04-03       Impact factor: 20.096

9.  Transurethral resection of the prostate for benign prostatic hypertrophy: factors associated with a successful outcome at 1 year.

Authors:  H A Doll; N A Black; K McPherson
Journal:  Br J Urol       Date:  1994-06

10.  The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS.

Authors:  Chris C Sexton; Karin S Coyne; Zoe S Kopp; Debra E Irwin; Ian Milsom; Lalitha P Aiyer; Andrea Tubaro; Christopher R Chapple; Alan J Wein
Journal:  BJU Int       Date:  2009-04       Impact factor: 5.588

View more
  8 in total

Review 1.  How I Handle Retreatment of LUTS Following a Failed MIST.

Authors:  Alexis E Te; Ahra Cho; Bilal I Chughtai
Journal:  Curr Urol Rep       Date:  2021-06-11       Impact factor: 3.092

2.  High-power HoLEP: no thanks!

Authors:  Cesare Marco Scoffone; Cecilia Maria Cracco
Journal:  World J Urol       Date:  2018-01-27       Impact factor: 4.226

3.  Green Light photoselective vaporization of the prostate: a safe and effective treatment for elderly high-risk benign prostate hyperplasia patients with gland over 80 ml.

Authors:  Jie Sun; An Shi; Zhen Tong; Chenfei Chi
Journal:  Lasers Med Sci       Date:  2018-04-28       Impact factor: 3.161

4.  Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study.

Authors:  Sascha A Ahyai; Irina Marik; Tim A Ludwig; Andreas Becker; Saman Asdjodi; Luis Kluth; Felix Chun; Margit Fisch; Marianne Schmid
Journal:  World J Urol       Date:  2020-02-21       Impact factor: 4.226

5.  Patient satisfaction after holmium laser enucleation of the prostate (HoLEP): A prospective cohort study.

Authors:  Young Ju Lee; Shin Ah Oh; Sung Han Kim; Seung-June Oh
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

Review 6.  Optimising patient outcomes with photoselective vaporization of the prostate (PVP): a review.

Authors:  Claire Pascoe; Darren Ow; Marlon Perera; Henry H Woo; Greg Jack; Nathan Lawrentschuk
Journal:  Transl Androl Urol       Date:  2017-07

7.  Influence of solifenacin on the improvement of storage symptoms in the early period after photoselective vaporization of the prostate.

Authors:  Su Jin Kim; Woong Jin Bae; Sae Woong Kim
Journal:  Investig Clin Urol       Date:  2019-10-22

8.  Endoscopic enucleation vs endoscopic vaporization procedures for benign prostatic hyperplasia: how should we choose: A protocol for systematic review and meta-analysis.

Authors:  Xinbao Yin; Jun Chen; Hui Sun; Ming Liu; Zehua Wang; Benkang Shi; Xueping Zheng
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.